NCT06419361招募中早期 1 期
[68Ga]Ga-Sa-DABI-4 PET Imaging of Stimulator of Interferon Gene Expression in Cancer Patients
First Affiliated Hospital of Chongqing Medical University1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年5月30日最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 早期 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- Diagnostic efficacy
研究概览
简要总结
Stimulator of interferon gene (STING) protein plays a vital role in the immune surveillance of tumor microenvironment. Monitoring STING expression in tumors benefits the relevant STING therapy. This study will investigate the safety, biodistribution and potential usefulness of a novel 68Ga-labeled agonist ([68Ga]Ga-Sa-DABI-4) for noninvasive positron emission tomography (PET) imaging of STING expression in the tumor microenvironment.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •At least 18 years of age.
- •Signed informed consent.
- •Patients with suspected or newly diagnosed or previously malignant disease.
排除标准
- •Patients with non-malignant disease.
- •Patients with pregnancy.
- •The inability or unwillingness of the research participant, parent or legal representative to provide written informed consent.
- •Known or expected hypersensitivity to [68Ga]Ga-Sa-DABI-4 or any of its components.
- •Any serious medical condition or extenuating circumstance which the investigator feels may interfere with the procedures or evaluations of the study.
研究组 & 干预措施
[68Ga]Ga-Sa-DABI-4
Experimental
Patients will receive a single administration of [68Ga]Ga-Sa-DABI-4.
干预措施: [68Ga]Ga-Sa-DABI-4 (Drug)
结局指标
主要结局
Diagnostic efficacy
时间窗: 15 days
The sensitivity, specificity, and accuracy of \[68Ga\]Ga-Sa-DABI-4 PET
次要结局
未报告次要终点
研究者
Xiaoyang Zhang
Principal Investigator
First Affiliated Hospital of Chongqing Medical University
研究点 (1)
Loading locations...
相似试验
Enrolling By Invitation
不适用
PET Imaging of Cancer Patients Using 68Ga-DOTA-Siglec-9Non Small Cell Lung CancerAcute Myeloid LeukemiaMelanomaNCT05212103Turku University Hospital30
招募中
早期 1 期
68Ga-DOTA-NI-FAPI04 PET/CT in Patients With Various Types of CancerTumorNCT06455761First Affiliated Hospital of Fujian Medical University30
Unknown
早期 1 期
68Ga-DOTATATE PET/CT in Neuroendocrine TumorNeuroendocrine TumorsNCT04041882Peking Union Medical College Hospital100
已完成
1 期
68Ga-grazytracer PET/CT of Tumor Responses to ImmunotherapyCancerNCT05000372Peking University Cancer Hospital & Institute24
Unknown
早期 1 期
Diagnosis of Metastatic Tumors on 68Ga-FAPI PET-CT and Radioligand Therapy With 177Lu-EB-FAPI177Lu-EB-FAPINCT05400967Peking Union Medical College Hospital10